share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  08/28 18:09
牛牛AI助理已提取核心訊息
SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-281220, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities.
SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-281220, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities.
SeaStar醫療控股公司已宣佈在2024年8月27日下午4:30,向美國證券交易所(SEC)提交了S-3表格,該提交編號爲333-281220,這對公司來說是一個重要步驟,表示公司已滿足必要的SEC要求以發行證券。
SeaStar醫療控股公司已宣佈在2024年8月27日下午4:30,向美國證券交易所(SEC)提交了S-3表格,該提交編號爲333-281220,這對公司來說是一個重要步驟,表示公司已滿足必要的SEC要求以發行證券。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。